Arkolith/Insider Trading/NVCT/Form 4

Poradosu Enrique

Chief Science & Business OffNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed May 13, 2024
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 10, 2024Buy(P)500$6.29$3K1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-060262) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML